Uzbekistan
Diabetes country report 2011 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Uzbekistan (UZ)
| 2011 | 812.9 thousand |
| 2024 | 1.5 million |
| 2050 | 2.2 million |
Uzbekistan is one of the 60 countries and territories in the IDF Europe Region.
Data source(s) used for the diabetes estimates in adults:
- Alieva A.V., Ismailov S.I., Rakhimova G.N. Epidemiology of diabetes mellitus and prediabetes in Uzbekistan. 2016.
- WHO STEPS 2014.
- Anna Alieva, Anvar Alimov, Feruza Khaidarova, Saidiganikhoja Ismailov, Gulnara Rakhimova, Dilorom Nazhmutdinova, Barno Shagazatova and Victoria Tsareva. 2019. Data received ahead of publication.
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | - | 812.9 | 1,501.9 | 2,220.6 |
| Age-standardised prevalence of diabetes, % | - | 6.4 | 7.5 | 7.6 |
| Proportion of people with undiagnosed diabetes, % | - | - | 74.0 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 1,111.4 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 266.9 | 472.2 |
| Age-standardised prevalence of IFG, % | - | - | 1.4 | 1.7 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 764.9 | 686.7 | 1,214.4 |
| Age-standardised prevalence of IGT, % | - | 5.9 | 3.7 | 4.3 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 11,449.0 | 7,447.4 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 4.8 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 315.7 | 416.4 |
| Total diabetes-related health expenditure, ID million | - | - | 1,763.0 | 2,325.3 |
| Diabetes-related health expenditure per person, USD | - | 80.0 | 210.2 | 187.5 |
| Diabetes-related health expenditure per person, ID | - | - | 1,173.9 | 1,047.1 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 15,548.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 4,839.7 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | - | 16,397.4 | 21,888.0 | 30,914.5 |
| Population of children and adolescents (0-19 y) | - | - | 14,092,923.5 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | - |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | - |
| Population of children and adolescents (0-19 y) | - |
